Myocardial infarction occurring in a case of acquired haemophilia during the treatment course with recombinant activated factor VII

被引：0
|
作者：
Guillet, B [1 ]
Pinganaud, C
Proulle, V
Dreyfus, M
Lambert, T
机构：
[1] Hop Bicetre, AP HP, Ctr Traitement Malad Hemorrag, F-94275 Le Kremlin Bicetre, France
[2] Hop Bicetre, AP HP, Hematol Lab, F-94275 Le Kremlin Bicetre, France
[3] Hop Bicetre, AP HP, Serv Med Interne, F-94275 Le Kremlin Bicetre, France
[4] Fac Med Paris XI, Le Kremlin Bicetre, France
来源：
THROMBOSIS AND HAEMOSTASIS | 2002年 / 88卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：698 / 699
页数：2
相关论文
共 50 条
  • [31] Determinants of drug costs in hospitalised patients with haemophilia - Impact of recombinant activated factor VII
    Galanaud, JP
    Pelletier-Fleury, N
    Logerot-Lebrun, H
    Lambert, T
    PHARMACOECONOMICS, 2003, 21 (10) : 699 - 707
  • [32] Utilization of recombinant activated factor VII in southern Ontario in 85 patients with and without haemophilia
    Webert, K. E.
    Arnold, D. M.
    Carruthers, J.
    Molnar, L.
    Almonte, T.
    Decker, K.
    Seroski, W.
    Reed, J.
    Chan, A. K.
    Pai, M.
    Walker, I. R.
    HAEMOPHILIA, 2007, 13 (05) : 518 - 526
  • [33] Myocardial infarction following recombinant activated factor VII in a patient with type 2A von Willebrand disease
    Basso, IN
    Keeling, D
    BLOOD COAGULATION & FIBRINOLYSIS, 2004, 15 (06) : 503 - 504
  • [34] A Case Report of a Recombinant Porcine Factor VIII Usage in Acquired Haemophilia A
    Ewins, K. T.
    Singleton, E.
    Byrne, M.
    O'Connell, N.
    Ryan, K.
    HAEMOPHILIA, 2017, 23 : 91 - 92
  • [35] Treatment of acute bleeds with recombinant activated factor VII during immune tolerance therapy
    Petrini, P
    Klementz, G
    BLOOD COAGULATION & FIBRINOLYSIS, 1998, 9 : S143 - S146
  • [36] Decreased transfusion requirements in acquired severe bleeding with recombinant activated factor VII
    Lecumberri, R
    Páramo, JA
    Hidalgo, F
    Feliu, J
    Iglesias, R
    Rocha, E
    MEDICINA CLINICA, 2005, 125 (07): : 252 - 253
  • [37] Severe acquired hemophilia A successfully treated with activated recombinant human factor VII
    Papadaki, HA
    Xylouri, I
    Valatas, W
    Petinarakis, J
    Kontopoulou, I
    Eliopoulos, GD
    ANNALS OF HEMATOLOGY, 1998, 77 (03) : 123 - 125
  • [38] The use of recombinant activated factor VII in congenital and acquired von Willebrand disease
    Franchini, Massimo
    Veneri, Dino
    Lippi, Giuseppe
    BLOOD COAGULATION & FIBRINOLYSIS, 2006, 17 (08) : 615 - 619
  • [39] Severe acquired hemophilia A successfully treated with activated recombinant human factor VII
    H. A. Papadaki
    I. Xylouri
    W. Valatas
    J. Petinarakis
    I. Kontopoulou
    G. D. Eliopoulos
    Annals of Hematology, 1998, 77 : 123 - 125
  • [40] The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: A multicentre study
    Hay, CRM
    Negrier, C
    Ludlam, CA
    THROMBOSIS AND HAEMOSTASIS, 1997, 78 (06) : 1463 - 1467
12345